THEMISMED — Themis Medicare Income Statement
0.000.00%
- IN₹12.10bn
- IN₹12.69bn
- IN₹3.82bn
- 82
- 17
- 16
- 29
Annual income statement for Themis Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,016 | 2,307 | 3,946 | 3,543 | 3,818 |
Cost of Revenue | |||||
Gross Profit | 1,270 | 1,435 | 2,261 | 2,194 | 2,268 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,741 | 1,897 | 3,085 | 2,974 | 3,425 |
Operating Profit | 275 | 409 | 862 | 570 | 393 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 269 | 413 | 953 | 725 | 534 |
Provision for Income Taxes | |||||
Net Income After Taxes | 248 | 357 | 729 | 569 | 435 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 248 | 357 | 729 | 569 | 435 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 248 | 357 | 729 | 569 | 435 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.7 | 3.88 | 7.91 | 6.17 | 4.72 |
Dividends per Share |